Erik Johnson
- Department of Neurology
Assistant Professor
-
Emory University
Department of Neurology & Alzheimer's Disease Research Center
615 Michael Street - Whitehead Building Suite 505C
Academic Appointment
- Assistant Professor, Neurology, Emory University
Education
Degrees
- Ph.D., Biochemistry and Molecular Biology from University of Chicago
- M.D. from University of Chicago
- B.A., Biology; B.A., Chemistry from Augsburg College
Research
Focus
-
Molecular Biomarkers for Neurodegenerative Diseases
Research is currently focused on developing biofluid protein-based molecular biomarkers for neurodegenerative diseases -- with an emphasis on Alzheimer's disease -- for diagnostic, prognostic, and therapeutic uses.
Publications
-
Author Correction: Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.
Nat Aging
07/07/2025 Authors: Saloner R; Staffaroni AM; Dammer EB; Johnson ECB; Paolillo EW; Wise A; Heuer HW; Forsberg LK; Lario-Lago A; Webb JD -
Proteomic analysis of Down syndrome cerebrospinal fluid compared to late-onset and autosomal dominant Alzheimers disease.
Nat Commun Volume: 16 Page(s): 6003
07/01/2025 Authors: Montoliu-Gaya L; Bian S; Dammer EB; Alcolea D; Sauer M; Mart-Ariza M; Ashton NJ; Belbin O; Fuchs J; Watson CM -
Large-scale network analysis of the cerebrospinal fluid proteome identifies molecular signatures of frontotemporal lobar degeneration.
Nat Aging Volume: 5 Page(s): 1143 - 1158
06/01/2025 Authors: Saloner R; Staffaroni AM; Dammer EB; Johnson ECB; Paolillo EW; Wise A; Heuer HW; Forsberg LK; Lario-Lago A; Webb JD -
The association between pulse wave velocity and cerebrospinal fluid biomarkers for Alzheimer's disease.
J Alzheimers Dis Volume: 105 Page(s): 729 - 735
06/01/2025 Authors: Kim H; Kulshreshtha A; Alonso A; Goldstein FC; Johnson EC; Gold ME; Quyyumi AA; Lah JJ -
Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials.
J Prev Alzheimers Dis Volume: 12 Page(s): 100075
04/01/2025 Authors: Hammers DB; Musema J; Eloyan A; Thangarajah M; Taurone A; La Joie R; Touroutoglou A; Vemuri P; Kramer J; Aisen P -
Longitudinal analysis of a dominantly inherited Alzheimer disease mutation carrier protected from dementia.
Nat Med Volume: 31 Page(s): 1267 - 1275
04/01/2025 Authors: Llibre-Guerra JJ; Fernandez MV; Joseph-Mathurin N; Bian S; Carter K; Li Y; Aschenbrenner AJ; Pottier C; Sigurdson W; McDade E -
Proteomic Subtyping of Alzheimer's Disease CSF links Blood-Brain Barrier Dysfunction to Reduced levels of Tau and Synaptic Biomarkers.
03/15/2025 Authors: Bangs MC; Gadhavi J; Carter EK; Ping L; Duong DM; Dammer EB; Wu F; Shantaraman A; Fox EJ; Johnson ECB -
Plasma proteins associated with the brain age gap.
Nat Aging Volume: 5 Page(s): 15 - 16
01/01/2025 Authors: Johnson ECB -
Author Correction: Serum proteomics reveal APOE-4-dependent and APOE-4-independent protein signatures in Alzheimer's disease.
Nat Aging Volume: 4 Page(s): 1509
10/01/2024 Authors: Frick EA; Emilsson V; Jonmundsson T; Steindorsdottir AE; Johnson ECB; Puerta R; Dammer EB; Shantaraman A; Cano A; Boada M -
Serum proteomics reveal APOE-4-dependent and APOE-4-independent protein signatures in Alzheimer's disease.
Nat Aging Volume: 4 Page(s): 1446 - 1464
10/01/2024 Authors: Frick EA; Emilsson V; Jonmundsson T; Steindorsdottir AE; Johnson ECB; Puerta R; Dammer EB; Shantaraman A; Cano A; Boada M